Overview
Key stats
Fundamentals Sep 9- Open
- $120.00
- 52-wk high
- $127.50
- High
- $121.63
- 52-wk low
- $92.41
- Low
- $119.00
- Prev close
- $120.47
- Mkt cap
- $11.88B
- P/E
- 20.1x
- Volume
- 621.0K
- Fwd P/E
- 18.9x
- Beta
- 0.61
- Div yield
- 0.62%
- P/S
- 1.9x
- P/B
- 4.6x
- Profit margin
- +10.0%
- Op margin
- +18.0%
- ROE
- +25.0%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsSmart money
8 funds hold a position and insiders have been net selling.
What funds are doing
12 moves · 6 mo
Buys/Adds$463.3MSells/Trims$303.8M
Activist stakes, short interest & more
2 items
Earnings
Earnings came in 4.7% above what analysts expected.
Earnings per share
$1.55+4.7%
$1.48 expected
What the street expects next
EPS expected
$1.36
$1.25 to $1.45
Revenue expected
$1.60B
11 analysts
Last 30 days
7up4down
Analysts raising estimates
Financials
What it sold, what it cost, what was left.
Sep 2025Dec 2025Mar 2026Jun 2026
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $1.48B | $1.54B | $1.59B | $1.60B |
| Cost of what it sold | $784.8M | $64.5M | $818.1M | $66.1M |
| Gross profit | $692.7M | $1.48B | $768.5M | $1.60B |
| What it spent | ||||
| Sales and admin | $56.1M | $884.0M | $58.2M | $62.6M |
| Other operating costs | $393.0M | $312.7M | $408.7M | $1.25B |
| Total operating expenses | $449.1M | $1.20B | $466.9M | $1.31B |
| What was left | ||||
| Operating profit | $243.6M | $283.4M | $301.6M | $288.4M |
| Interest on debt | $30.8M | $30.2M | $31.8M | $32.8M |
| Profit before tax | $219.9M | $257.7M | $288.7M | $261.6M |
| Tax | $44.9M | $55.4M | $56.4M | $53.6M |
| Net profit | $126.5M | $146.1M | $194.5M | $153.9M |
| EBITDA | $333.1M | $374.3M | $407.8M | $384.8M |
Technicals
Price structure
This stock is trending upward.
Trend
Constructive
60 / 100
RSI 14
49balanced
20D volatility
13%annualized
52-week range
$92.41$127.50
20D support
$118.77recent floor
20D resistance
$126.10recent ceiling
Returns
5D -0.4%20D -3.1%60D +20.0%
Price vs moving averages
SMA20 -0.0%SMA50 +4.7%SMA200 +13.5%
Volume pace
0.86xvs prior 20D
News
What the news says
1 article · 7 days
Coverage is neutral
Tone of tracked coverage
Why Is Encompass Health (EHC) Down 1.8% Since Last Earnings Report?
NeutralSep 5
Macro
21 macro signals shaping EHC right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results